Abstract:Background: Hypoxia is one of the hallmarks of cancer and is associated with poor prognosis. However, the molecular mechanism by which hypoxia promotes tumor progression remains unclear. MicroRNAs participate in almost all biological processes through posttranscriptional regulation of the expression of multiple genes. In thecurrent study, we found that two miRNAs, miR-495 and miR-5688, participate in NSCLC progression under hypoxia. Methods: The expression of miR-495 and miR-5688 in human tissue specimens was measured by quantitative RT-PCR (qRT-PCR). Colony formation, MTS, wound healing, and transwell assays and a xenograft model were used to evaluate the role of miR-495 and miR-5688 in tumor progression. Two algorithms, PicTar and TargetScan, were used to predict miRNA targets, and a dual-luciferase reporter assay was used to confirm the target. Findings: MiR-495 and miR-5688 were downregulated in NSCLC tissues compared with normal tissues. We determinedthat hypoxia led to the downregulation of miR-495 and miR-5688 in NSCLC cells. In addition, miR-495 and miR-5688 suppressed cell proliferation, migration and invasion in vitro. The NSCLC xenograft model showed that miR-495 and miR-5688 inhibited tumor formation in vivo. Interestingly, we found that miR-495 and miR-5688 had the same target, IL-11. Furthermore, a series of rescue experiments demonstrated that miR-495 and miR-5688 executed their tumor suppressive role by repressing IL-11 expression. Interpretation: We identified two new players, miR-495 and miR-5688, that participate in NSCLC progression under hypoxia. Mechanistically, hypoxia downregulates miR-495 and miR-5688 in NSCLC to enhance IL-11 expression and tumor progression. Our study indicates that the miR-495/miR-5688/IL-11 axis may serve as a therapeutic target and potential biomarker for NSCLC. Funding Statement: This work was supported by the National Natural Science Foundation of China (Grant No. 81602026) and the Natural Science Foundation of Tianjin (Grant No. 18JCQNJC81600 and 18JCZDJC32600). Declaration of Interests: The authors declare that they have no competing interests. Ethics Approval Statement: All samples were obtained with informed consent, and the study was approved by the Ethics Committee of Tianjin Medical University Cancer Institute and Hospital. All mouse studies were approved by the Animal Ethics Committee of Tianjin Medical University.

MicroRNA 101 Attenuated NSCLC Proliferation Through IDH2/HIFα Axis Suppression in the Warburg Effect

MiR-101-3p Targets KPNA2 to Inhibit the Progression of Lung Squamous Cell Carcinoma Cell Lines.

MicroRNA-101 Suppresses Progression of Lung Cancer Through the PTEN/AKT Signaling Pathway by Targeting DNA Methyltransferase 3A.

Loss of MiR-192-5p Initiates a Hyperglycolysis and Stemness Positive Feedback in Hepatocellular Carcinoma.

Data Supplement from IL-1β-Mediated Repression of microRNA-101 Is Crucial for Inflammation-Promoted Lung Tumorigenesis

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Mir‑654‑3p Suppresses Cell Viability and Promotes Apoptosis by Targeting RASAL2 in Non‑small‑cell Lung Cancer.

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

Prognostic Implications of Decreased Microrna-101-3p Expression in Patients with Non-Small Cell Lung Cancer

MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia

Non-Small Cell Lung Cancer Downregulates miR-495 and miR-5688 Under Hypoxia to Maintain&nbsp;Interleukin-11 Expression

Microrna-320B Suppresses HNF4G and IGF2BP2 Expression to Inhibit Angiogenesis and Tumor Growth of Lung Cancer.

MicroRNA?101 Inhibits Proliferation, Migra?tion and Invasion of Human Glioblastoma by Targeting SOX9

Wild-type IDH2 Promotes the Warburg Effect and Tumor Growth Through HIF1α in Lung Cancer.

Mir-512-5p Induces Apoptosis and Inhibits Glycolysis by Targeting P21 in Non-Small Cell Lung Cancer Cells

MicroRNA-101 Targets Von Hippel-Lindau Tumor Suppressor ( VHL ) to Induce HIF1α Mediated Apoptosis and Cell Cycle Arrest in Normoxia Condition

IL-1β-mediated Repression of Microrna-101 is Crucial for Inflammation-Promoted Lung Tumorigenesis.

Microenvironment and Immunology IL-1 b-Mediated Repression of microRNA-101 Is Crucial for In fl ammation-Promoted Lung Tumorigenesis

MicroRNA-212 Displays Tumor-Promoting Properties in Non-Small Cell Lung Cancer Cells and Targets the Hedgehog Pathway Receptor PTCH1

Reduced Mir-105-1 Levels Are Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer.